Pre-order Enquiry
Request Free Sample
Global and United States Opioid Drugs Market Report & Forecast 2022-2028
SKU ID : QYR-20786404 | Publishing Date : 25-Apr-2022
Request Sample
Request Customization
Check Discounts
Opioid Drugs can act on the pain central system in the human brain, brainstem and other tissues, thus exerting a strong downward pain suppression effect.
Market Analysis and Insights: Global and United States Opioid Drugs Market
This report focuses on global and United States Opioid Drugs market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Opioid Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Buprenorphine accounting for % of the Opioid Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Anesthesia was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Opioid Drugs can not only bind to peripheral nerve opioid receptors, but also to opioid receptors in the gelatinous (second layer) sensory neurons of the spinal dorsal horn in the human body, and can also inhibit the Released, effectively preventing pain sensations from flowing into the brain.
Global Opioid Drugs Scope and Market Size
Opioid Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Opioid Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Opioid Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Buprenorphine
Fentanyl
Hydrocodone
Morphine
Oxycodone
Tramadol
Others
Segment by Application
Anesthesia
Pain relief
Cough suppression
Diarrhea suppression
Deaddiction
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Acura Pharmaceuticals
Cipher Pharmaceutical Inc.
Daiichi Sankyo
Johnson＆Johnson
Lupin Limited
Pfizer
Sun Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Market Analysis and Insights: Global and United States Opioid Drugs Market
This report focuses on global and United States Opioid Drugs market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Opioid Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Buprenorphine accounting for % of the Opioid Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Anesthesia was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Opioid Drugs can not only bind to peripheral nerve opioid receptors, but also to opioid receptors in the gelatinous (second layer) sensory neurons of the spinal dorsal horn in the human body, and can also inhibit the Released, effectively preventing pain sensations from flowing into the brain.
Global Opioid Drugs Scope and Market Size
Opioid Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Opioid Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Opioid Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Buprenorphine
Fentanyl
Hydrocodone
Morphine
Oxycodone
Tramadol
Others
Segment by Application
Anesthesia
Pain relief
Cough suppression
Diarrhea suppression
Deaddiction
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Acura Pharmaceuticals
Cipher Pharmaceutical Inc.
Daiichi Sankyo
Johnson＆Johnson
Lupin Limited
Pfizer
Sun Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
